XJPX
6062
Market cap286mUSD
Oct 09, Last price
1,404.00JPY
1D
1.30%
1Q
3.24%
Jan 2017
277.29%
IPO
1,397.60%
Name
Charm Care Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Charm Care Corporation specializes in the nursing care industry, operating fee-based residential facilities. The company manages approximately 4,191 rooms across its network of nursing homes, primarily situated in the Tokyo metropolitan and Kinki regions. Established in 1984, the organization initially operated as Fuji Clinic Laboratory before rebranding to Charm Care Corporation in December 2007. Its corporate headquarters are located in Osaka, Japan.
Key people
Shiro Kokaji
President, Chief Operating Officer, Manager of DX Promotion Office, Manager of Business Planning Office, Representative Director · since 2024
Tomokazu Yamada
Executive Officer, Director of Human Resources · since 2013
Keita Endo
Executive Officer, Manager of Business Planning Office · since 2024
Ikutaro Furukawa
Executive Officer, Manager of Risk Management · since 2024
Kota Ida
Executive Officer, Director of Metropolitan Area Nursing Care Business · since 2024
Hiroshi Kato
Executive Officer, Director of Real Estate Business · since 2022
Toshifumi Morimoto
Executive Officer, Director of Kinki Region Nursing Care Business · since 2025
Akiko Saito
Executive Officer, Director of Education and Training · since 2025
Yoshihiko Maeda
Executive Officer, Director · since 2023
Takahiko Shimomura
Chairman of the Board, Chief Executive Officer, Chairman of Subsidiary, Representative Director · since 2024
Shigeki Yokoyama
Executive Officer, Manager of Business Administration Office, President of Subsidiary, Director · since 2023
Kenji Nishimon
Independent Director · since 2020
Independent Director · since 2021
Tomokazu Yamazawa
Independent Director · since 2017
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||